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Although bioactive peptides can be obtained from whey protein hydrolysis, data about their immune
effects are inconclusive. The in vitro effects on the human immune system of different b-lactoglobulin
tryptic-digested fractions separated by membrane ﬁltration were evaluated, analysing the proliferation,
cytokine secretion and differentiation of human peripheral blood cells. This procedure allowed the
enrichment of peptide sets with speciﬁc features, suggesting that the differences in the peptidic
composition were related to their immune function. The fraction enriched in large and acid peptides was
able to induce Th1 responses, whereas fractions containing short peptides were involved in monocyte
activation increasing TNFa secretion. Moreover, one of these fractions was able to induce TGFb secretion
and regulatory T cell differentiation, key mechanisms by which whey-derived peptides could impair
allergic and inﬂammatory responses. No impact on immune cells was triggered by the unfractionated
hydrolysate, supporting the use of membrane-fractionating techniques for obtaining immune bioactive-
enriched fractions.
 2013 Published by Elsevier Ltd.
1. Introduction
Milk whey was formerly considered as a waste product from the
cheese industry. However, new evidence on its nutritional and
potential bioactive functions has led to the consideration of this
product as a source of valuable ingredients for the food industry. In
fact, it has been reported that peptides with several health-
promoting activities may be obtained from bovine whey (Riera,
Fernández, & Muro, 2012; Smithers, 2007).
It is known that primary sequences of whey proteins may
contain many biologically active peptides, speciﬁc short protein
fragments that have positive effects on human health apart from
their nutritional characteristics (Kitts & Weiler, 2003). These pep-
tides show no effects when contained within the whole protein
sequence, but they can be released by enzymatic proteolysis. Since
the levels of bioactive peptides released during digestion of bovine
whey proteins in adults is probably too low to develop effects on
human health in vivo (Gauthier, Pouliot, & Saint-Sauveur, 2006),
regularly consumed dairy products could be supplemented with
speciﬁc bioactive peptide-enriched fractions. In this sense, enzy-
matic hydrolysis followed by membrane fractionation (Pihlanto &
Korhonen, 2003) could supply enriched fractions with different
biological effects.
Bioactive peptides from whey proteins, mainly b-lactoglobulin
(b-LG), are reported to have opioid (Antila et al., 1991), antimicro-
bial (Pellegrini, Dettling, Thomas, & Hunziker, 2001), antioxidative
(Pena-Ramos & Xiong, 2001), antithrombotic (Pihlanto & Korhonen,
2003), hypocholesterolaemic (Madureira, Tavares, Gomes, Pintado,
& Malcata, 2010), antihypertensive (Mullally, Meisel, & FitzGerald,
1997; Pihlanto-Leppälä & Korhonen, 1998), mineral-binding
(Pihlanto & Korhonen, 2003) as well as immune effects (Pihlanto
& Korhonen, 2003).
Recently, several studies have focused on the immunomodula-
tory activity of whey protein hydrolysates by assessing their
effects on lymphocyte activation and proliferation, cytokine
secretion, antibody production and promoting phagocytic activity
(Gauthier et al., 2006). However, different and even opposite
immunomodulatory effects have been described, probably due to
the involvement of different bioactive peptides. Among the re-
ported immunomodulatory effects, there are suppressive activities.
These effects are of growing interest since they could have a role in
preventing or improving common diseases whose prevalence have
increased in recent decades, such as atopic allergies or inﬂamma-
tory pathologies (von Mutius, Fritzsch, Weiland, Roll, & Magnussen,
1992). In this scenario, anti-inﬂammatory cytokines and regulatory
T cells (Treg) may be important mediators, since they are
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competent suppressors of effector immune responses, mainly
mediated by T helper (Th) cells (Elkord, 2008). Accordingly, some
nutraceuticals have been shown to impact on Treg numbers or
function both in vivo and in vitro (Issazadeh-Navikas, Teimer, &
Bockermann, 2012; Wang et al., 2012).
In line with this immunoregulatory effect, the hydrolysis of
whey protein has been considered an effective way to produce
hypoallergenic milk formulae, adequate to prevent the develop-
ment of allergy to cows’ milk proteins in children, as well as in
adults at risk (Szajewska & Horvath, 2010; von Berg et al., 2008). In
this sense, enzymatic cleavage of whey proteins has been consid-
ered the main mechanism for avoiding immune adverse reactions,
since it was assumed that allergenic epitopes were mostly dimin-
ished by the enzymatic treatment (Knipping et al., 2012). However,
several studies highlight the possibility that speciﬁc immunoreg-
ulatory mechanisms may also have a role in the hypoallergenic
proﬁle (Pecquet, Bovetto, Maynard, & Fritsche, 2000). That is, as
occurs with peripheral immune tolerance, hypoallergenicity could
not only be maintained by a passive mechanism (hydrolysis of the
allergenic proteins), but also by an active immunoregulatory effect,
such as the generation of suppressive cytokines and/or regulatory
cells after the interaction of immune cells with speciﬁc peptides.
The main aim of the present study was to evaluate the potential
immunomodulatory activities of different peptidic fractions ob-
tained after membrane separation of a b-LG tryptic hydrolysate,
analysing the effect on human peripheral blood immune cell pro-
liferation, cytokine production and lymphocyte differentiation.
2. Material and methods
2.1. Preparation of different bovine b-LG fractions
The total hydrolysate (TH) sample was obtained after the
enzymatic hydrolysis of bovine b-LG (Davisco Food Co., city, MN,
USA) with modiﬁed trypsin (T1426.1G, Sigma, St. Louis, MO,
USA). The protein content of the commercial substrate was 97.9%
(w/w), representing 91.5% b-LG, and the trypsin was treated with
L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK) to
reduce chymotrypsin activity. The hydrolysis was carried out
under the optimum temperature and pH conditions for enzyme
activity, i.e., 37 C and 8.0, respectively, and at a ﬁnal enzyme/
substrate ratio (E/S) of 1/250. A 2.5 L solution containing 15 g L 1
of the substrate was used for hydrolysate preparation as previ-
ously described by Fernández Suárez, Zhu, FitzGerald, and Riera
(2013) with few modiﬁcations. The TH sample was taken after
24 h of reaction.
The tryptic hydrolysate was ﬁltered using a Pellicon 2 mini
holder (Millipore, city/state, USA) equipped with three different
tangential ﬂow membrane cassettes: two polyethersulfone mem-
branes having cut offs of 1 kDa (Sartorius; Göttingen, Germany) and
5 kDa (Millipore; city, MA, USA), respectively, and a stabilised cel-
lulose membrane of 2 kDa cut off (Sartorius; Göttingen, Germany).
Each membrane has a ﬁltration area of 0.1 m2. The fractionation
experiments were carried out with no salt addition and at pH 8.0
according to Fernández et al. (2013), Fernández and Riera (2013a).
Transmembrane pressure and the temperature of the hydrolysate
were set to 7.5 ! 104 Pa and 37 C, respectively. Fractions denoted
by PES-1, PES-5 and HYD-2 correspond with the permeate streams
obtained using the 1 kDa polyethersulfone membrane, 5 kDa pol-
yethersulfone membrane and 2 kDa Hydrosart membrane,
respectively. Finally, the fraction composed of the peptides rejected
by the 5 kDa polyethersulfone membrane, after a continuous dia-
ﬁltration process, was termed the DR fraction. Distilled water was
added to the hydrolysate during the diaﬁltration process at the
same rate as the permeate was generated until a diaﬁltration
volume of 7.5 L was reached. All the samples were then freeze-dried
and stored at  20 C prior their use.
2.2. Analysis of peptide composition
All the freeze-dried samples were analysed using a reversed
phase-high performance liquid chromatography (RP-HPLC) system
(Agilent 1200 series, Agilent Technologies; city, CA, USA) and the
peptides present in the TH chromatographic proﬁle (Fig. 1A) were
identiﬁed by mass spectrometry (MS) analysis as previously
described (Fernández & Riera, 2013b).
Table 1 shows the physico-chemical characteristics of the
identiﬁed peptides, which are responsible for membraneepeptide
interactions in this fractionation process. The molar concentration
of the peptides was calculated from the peak area in the chro-
matograms according to Eq. (1) (Muñoz-Tamayo et al., 2012).
xj ¼ 1! 10
6
 
Aj
εj$l$v
!
$f (1)
where xj (mM) is the concentration of the peptide j, Aj (AU deﬁne
AU ! min) the area of the HPLC peak of peptide j at 214 nm, l
(0.6 cm) the path length of the UV cell, v (20 mL) the injection
volume, f (1000 mL min 1) the ﬂow rate and εj (AU M
 1 cm 1) the
molar extinction coefﬁcient of peptide j at 214 nm calculated ac-
cording to Kuipers and Gruppen (2007).
2.3. Peripheral blood mononuclear cell isolation
Human peripheral blood mononuclear cells (PBMC) were ob-
tained from healthy donors buffy coat preparations (Blood Trans-
fusion Centre, Oviedo) by centrifugation over Ficoll-Hyplaque
gradient (Lymphoprep, PAA Laboratories GmbH, Cölbe, Ger-
many). After washing twice with sterile phosphate buffered saline
(PBS), PBMC were resuspended at 2 ! 106 cells mL 1 in RPMI 1640
medium (BioWhittaker; Verviers, Belgium) supplementedwith 10%
heat-inactivated foetal calf serum (FCS; PAA Laboratories GmbH)
and 100 mg mL 1 streptomycin and ampicillin (Sigma). Blood do-
nors (n ¼ 12) were healthy adults, regular consumers of dairy
products, with neither pathology nor treatment at the time of
donation. Approval for this study was obtained from the Regional
Ethics Committee for Clinical Investigation (Asturias, Spain).
2.4. PBMC proliferation assay
Peptide fractions were dissolved in sterile complete RPMI 1640
(BioWhittaker) and were kept at 4 C for 1e2 h before culture as-
says. The solubility of the samples for the cell cultures was checked
prior to the assays and it as always complete. Then, peptide solu-
tions were added to 2 ! 106 PBMC cells in 96-well round-bottom
plates and a range of concentrations of 0.1e104 mg mL 1 were
tested (each concentration was assayed in quadruplicate). No sig-
niﬁcant differences in the pH of the culture mediumwere detected
at the studied concentrations. The assay was performed under
resting and phytohaemagglutinin (PHA)-stimulating (2.5 mg mL 1;
Sigma) conditions. The plates were incubated at 37 C in a 5% CO2
atmosphere. On day 4 of culture, the cells were pulsed with 1 mCi
3H-thymidine (Perkin Elmer; Boston, MA, USA) per well and, after
16 h, the cells were harvested onto glass microﬁbre ﬁlters and
proliferation was quantiﬁed using a Wallac Scintillation Liquid
Counter (Perkin Elmer). Results were determined as a stimulation
index (SI), which was calculated as the ratio between the mean
counts perminute (cpm) valuesmeasured in each culture condition
and the mean cpm values measured in unstimulated wells.
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2.5. Cytokine analyses
The supernatants from 5 day cultured PBMC were collected and
stored at 20  C until cytokine measurement. Levels of human
tumour necrosis factor alpha (TNFa), interferon gamma (IFNg) and
transforming growth factor beta (TGFb) were measured using
commercial OptEIA kits (BD Biosciences; Heidelberg, Germany),
according to the manufacturer’s instructions. Detection limits for
TNFa, IFNg and TGFb1 were 1.95 pg mL1, 1.17 pg mL1 and
31.5 pg mL1, respectively. All assays have a within-run imprecision
(coefﬁcient of variation) of <7%, and a between-run coefﬁcient of
variation of <10%. Results are the mean of four different donors. All
the peptidic fractions at the different assayed concentrations
showed undetectable levels of these cytokines, thus excluding the
possibility of direct binding of cytokines to sample peptides or
cross-reactivity in the cited immunoassays.
2.6. Flow cytometry analysis
To determine regulatory T cell population (Treg), phenotype of
PBMC after culture with the different peptidic fractions was
studied by ﬂow cytometry. Cells were cultured as previously
described and, after 5 days, they were collected and washed
twice with PBS. Then, cells were incubated for 30 min at 4  C in
the presence of a viability dye (Fixable Viability Dye eFluor 450,
eBioscience, San Diego, CA, USA), so as to exclude non-viable
cells from the ﬂow cytometry analysis. After that, extracellular
staining with anti-CD4 APC (BD Biosciences), anti-CD25 FITC (BD
Biosciences) and anti-CD127 PE-Cy7 (eBioscience) were per-
formed for 30 min at 4  C and then cells were washed again.
Next, cells were ﬁxed and permeabilised (FOXP3/transcription
factor staining buffer set, eBioscience), followed by an intracel-
lular staining with anti-FOXP3 PE (clone PCH101, eBioscience), or
a PE isotype-conjugated irrelevant antibody (BD Biosciences
Pharmingen, San Diego, CA, USA) as a negative control. Finally,
cells were washed again and analysed in a FACS Canto II cy-
tometer (BD Biosciences), equipped with three lasers (excitation
405 nm, 488 nm and 633 nm) using the FACS Diva v.2.4 software
(BD Biosciences).
To quantify Treg population, lymphocytes were gated using
forward- and side-scatter parameters. Paciﬁc Blue-stained cells
were excluded, since they were non-viable. CD4þ cells were then
gated and CD25, FOXP3 and CD127 expression was established
according to isotype control ﬂuorescence. A minimum of 30,000
CD4þ T lymphocytes was acquired. Data were expressed as a per-
centage of viable CD4þ T cells.
Fig. 1. Chromatographic proﬁles of the b-lactoglobulin fractions studied. Panel A: chromatographic proﬁle of the total hydrolysate before membrane separation; peptides are
identiﬁed in Table 1. Panel B: chromatographic proﬁles of the fractions obtained after permeation experiments with different membranes.
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2.7. Statistical analyses
The KolmogoroveSmirnov test was used to study normal dis-
tribution of the data. Since data were normally distributed, para-
metric methods were performed. Differences between samples
and controls in stimulation indices, cytokine levels and Treg fre-
quencies were determined using one-way analysis of variance
(ANOVA) and t-Dunnet multiple comparisons test. A p-value <0.05
was considered statistically signiﬁcant. SPSS 15.0 and GraphPad
Prism 5.00 (GraphPad Software, Inc., La Jolla, CA, USA) were used
for statistical analysis.
3. Results and discussion
3.1. Peptidic composition of the b-LG fractions
The evaluation of the chromatographic proﬁle of TH sample
(Fig. 1A) and the different fractions (Fig. 1B), and their peptidic
composition, presented in Table 2, showed that most larger pep-
tides were rejected by PES-1, HYD-2 and PES-5 membranes,
whereas those having a molecular mass lower than 1 kDa were
mainly transmitted to the permeate stream. In contrast, the chro-
matographic proﬁle corresponding to the DR sample showed an
Table 2
Peptidic composition of the freeze-dried fractions after membrane separation.
Peak numbera Peptide Sequenceb Peptide mass distribution in fractionsc
TH DR PES-5 HYD-2 PES-1
1 ALK f(139e141) 0.70 1.29 2.48 3.35 4.40
2 FDK f(136e138) 0.51 0.00 3.54 1.71 3.05
3 IIAEK f(71e75) 1.72 0.00 8.54 0.89 5.79
4 IDALNENK f(84e91) 2.53 0.00 4.24 0.00 1.68
5 GLDIQK f(9e14) 2.10 0.00 10.72 1.36 7.93
6 WEND(G)ECAQK þ WEND(G)ECAQKK f(61e69) þ f(61e70) 1.02 1.70 0.00 0.00 0.00
7 TPEVDDEALEK f(125e135) 1.40 2.16 4.10 0.49 1.79
8 LIVTQTMK f(1e8) 2.54 0.00 6.98 1.74 8.64
9 ALPMHIR f(142e148) 1.76 0.52 5.28 3.61 8.50
10 VAGTWY f(15e20) 1.07 0.00 5.38 7.49 6.68
11 IPAVFK f(79e83) 1.87 0.00 7.25 3.83 9.28
12 TKIPAVFK f(77e83) 0.33 0.00 0.47 0.26 0.71
13 VLVLDTDYK f(92e100) 2.12 0.00 3.13 0.18 1.48
14 TPEVDDEALEKFDK f(125e138) 2.55 3.72 0.00 0.00 0.00
15 WEND(G)ECAQKK þ LSFNPTQLEEQCHI f(61e70) þ f(149e162) 1.14 1.61 0.00 0.00 0.00
16 WEND(G)ECAQK þ LSFNPTQLEEQCHI f(61e69) þ f(149e162) 2.18 3.50 0.00 0.00 0.00
17 SLAMASSDISSLLDAQSAPLR f(21e40) 4.58 2.32 1.27 0.00 1.03
18 VYVEELKPTPEGDLEILLQK f(41e60) 8.90 13.37 0.00 0.00 0.00
19 VAGTWYSLAMASSDISSLLDAQSAPLR f(15e40) 0.52 0.41 0.00 0.00 0.21
Mass percentage of the sample attributed to the identiﬁed peptides 39.53 30.60 63.39 24.93 61.16
a Peak numbers according to the chromatogram in Fig. 1A.
b Amino acid interval within the sequence of the parent protein.
c The value for each peptide represents the mass percentage of this peptide in the different fractions after freeze drying. Fractions are: TH, total hydrolysate; DR, diaﬁltration
retentate; PES-5, 5 kDa polyethersulfone membrane permeate; HYD-2, 2 kDa Hydrosart membrane permeate; PES-1, 1 kDa polyethersulfone membrane permeate.
Table 1
Physico-chemical characteristics of the peptides contained in the b-lactoglobulin total hydrolysate sample.
Peak numbera Peptidic sequence (MS analysis) Sequenceb Molecular mass (Da) pIc A/B/Nd Chargee
pH 8
H4av
(kcal res 1)f
1 ALK f(139e141) 330.43 8.8 B 1 1.55
2 FDK f(136e138) 408.45 5.84 N 0 ( ) 1.38
3 IIAEK f(71e75) 572.7 6 N 0 ( ) 1.63
4 IDALNENK f(84e91) 916 4.37 A  1 0.95
5 GLDIQK f(9e14) 672.78 5.84 N 0 ( ) 1.14
6 WEND(G)ECAQK þ WEND(G)ECAQKK f(61e69) þ f(61e70) 2125.65e2183.65e2311.76 A
7 TPEVDDEALEK f(125e135) 1245.31 3.83 A  4 0.85
8 LIVTQTMK f(1e8) 933.17 8.75 B 1 1.34
9 ALPMHIR f(142e148) 837.05 9.8 B 1 1.54
10 VAGTWY f(15e20) 695.77 5.49 N 0 ( ) 1.46
11 IPAVFK f(79e83) 673.85 8.75 B 0 (þ) 2.02
12 TKIPAVFK f(77e83) 903.13 10.00 B 2 1.76
13 VLVLDTDYK f(92e100) 1065.23 4.21 A  1 1.44
14 TPEVDDEALEKFDK f(125e138) 1635.74 4.02 A  4 0.97
15 WEND(G)ECAQKK þ LSFNPTQLEEQCHI f(61e70) þ f(149e162) 2833.14 (2891.18) 4.91 (4.57) A  3 ( 4) 0.85
16 WEND(G)ECAQK þ LSFNPTQLEEQCHI f(61e69) þ f(149e162) 2704.97 (2763.01) 4.48 (4.25) A  2 ( 3) 0.82
17 SLAMASSDISSLLDAQSAPLR f(21e40) 2117.4 4.21 A  1 1.01
18 VYVEELKPTPEGDLEILLQK f(41e60) 2313.67 4.25 A  3 1.37
19 VAGTWYSLAMAASDISLLDAQSAPLR f(15e40) 2708.08 4.21 A  1 1.11
a Peak numbers according to the chromatogram in Fig. 1A.
b Amino acid interval within the sequence of the parent protein.
c Isoelectric points (pI) were calculated using the ExPASy Molecular Biology Server (http://www.expasy.org/).
d Classiﬁed as A: acidic (pI < 5), B: basic (pI > 7) and N: neutral (5 < pI < 7).
e Charge of the most abundant ion at pH 8.
f Average hydrophobicity calculated according to Bigelow (1967).
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almost complete absence of the smaller peptides such as f(136e
138), f(71e75) or f(84e91). As observed in Table 2, the sum of all the
identiﬁed peptides in the samples did not correspond with the total
amount of freeze-dried fraction used to perform the analysis. These
differences may be due to the presence of salts, unidentiﬁed pep-
tides and single amino acids. Partial solubilisation was observed
before the HPLC analysis (using Milli Q water as solvent), especially
in the case of the HYD-2 fraction. However, solubilisation was
checked as complete before the cell assays.
The differences in the peptidic composition of the isolated
fractions indicated that the membrane ﬁltration procedure used
here allowed the isolation of whey fractions containing peptides
with similar physico-chemical characteristics. Thus, the main
peptides present in PES-1 fraction, f(1e8), f(79e83) and f(142e
148), show a basic pI, positive charge and slightly higher values of
hydrophobicity than those present in the fractions HYD-2 and PES-
5, f(15e20) and f(9e14), f(71e75), respectively, which had lower pI
values, were neutral and uncharged. In contrast, the main peptides
in DR fraction, f(41e60) and f(125e138) had the lowest pI and were
negatively charged. Finally, it is interesting to note that the peptide
f(15e40), despite its charge and size, was unexpectedly present in
the PES-1 fraction, although it was completely absent in PES-5 and
HYD-2. Probably, peptideepeptide interactions could be a potential
explanation of why this peptide is surprisingly present in this
fraction, since aggregating properties have been reported (Groleau,
Morin, Gauthier, & Pouliot, 2003). In fact, this peptide has been
shown to interact with other peptides and this could impair the
separation of peptide mixtures (Groleau et al., 2003). This peptide
was also present in DR and TH samples, but accompanied in this
case by a number of other larger, acid and negatively charged
peptides. Thus, the large differences in peptide size, charge and
hydrophobicity detected among fractions, suggest that they could
induce different immune responses.
3.2. b-LG isolated fractions inﬂuence PBMC proliferation
To investigate the interaction between bovine b-LG peptides and
the human immune system in vitro, PBMCs were used as a
responder population to determine cellular proliferation and
cytokine production post-exposure with the different peptidic
fractions. Thus, PBMCs isolated from healthy individuals (resting
cells) were cultured in medium alone, as a negative control, or with
TH, PES-1, HYD-2, PES-5 and DR fractions or PHA, as a positive
control (Table 3). In addition, PHA-stimulated PBMCs were also
cultured with the different b-LG fractions to determine potential
additive or inhibitory effects (Table 4).
Table 3 shows that the DR fraction increased the proliferation of
resting cells in a dose-dependent manner within the range (10e
103 mg mL1), while PES-1, HYD-2 and PES-5 were also able to
induce a signiﬁcant proliferation at intermediate doses (102e
103 mg mL1), but exhibited a cytotoxic effect at the highest con-
centrations. Accordingly, microscopic observation revealed an
important loss of cell integrity in these cultures, with cells sur-
rounded by debris aggregates. Moreover, ﬂow cytometric analysis
showed a signiﬁcant decrease of viable cells at the highest con-
centration (76.68  3.64%, t-Dunnet post-hoc test: p < 0.001),
compared with both control cells (94.92  0.92%) and lower con-
centrations (103:93.73  1.30% and 102: 94.03  0.73%). Interest-
ingly, no signiﬁcant differences in cell proliferation were observed
with the TH fraction, probably due to the presence of a mixture of
heterogeneous peptides that could induce different and opposite
effects, thus leading to overall null effects. This ﬁnding is in
accordance with the idea that whey enzymatic cleavage by itself is
not enough to get signiﬁcant immune properties (Pihlanto &
Korhonen, 2003).
On the other hand, only the highest concentrations of PES-1,
HYD-2 or PES-5 provided an additive stimulation above the pro-
liferation rate of PHA-stimulated PBMCs (Table 4), suggesting that
the strong effect of PHA on PBMC proliferation (mean cpm value of
58,754  5869 versus 3645  319 cpm in resting cells) could mask
the slight effects induced by the peptide fractions. Interestingly, at
low doses (0.1e10 mg mL1), cells cultured with PES-1 showed a
slight suppression of proliferation compared with other fractions
(PES-1 versus HYD-2 and TH, p < 0.05 in all cases). DR fraction,
however, which was the strongest stimulant for resting cells, also
increased the proliferation index of PHA-stimulated cells at inter-
mediate concentrations, but it was cytotoxic at the highest con-
centration. Curiously, microscopic observation of DR cultures
revealed characteristic aggregates that did not appear in other
fractions. This ﬁnding may be related to the presence of the peptide
f(41e60), which has been reported as an aggregating agent
(Groleau et al., 2003). Similar to resting cells, no signiﬁcant prolif-
erative effect was observed with the TH fraction.
At this point, our results strongly suggested that all the isolated
bovine b-LG fractions, but not the TH, could exert effects on the
immune system, in particular PES-1, PES-5 and DR at intermediate
doses. However, the target cell population and the type of immune
response achieved by each fraction could be different; therefore,
functional experiments needed to be performed to understand
comparative effects among fractions.
3.3. Cytokine proﬁle depends on b-LG peptidic fraction
Subsequently, to determine the cytokine expression proﬁle
induced by the different b-LG fractions, the concentration of IFNg,
TNFa and TGFb cytokines was determined in PBMC culture super-
natants after 5 days of treatment. In view of previous results,
cytokine analyses were carried out in the supernatants from PES-1,
PES-5, DR and TH cultures at concentrations that led to optimal or
sub-optimal effects on PBMC proliferation (10e103 mg mL1), in
Table 3
Effects of different peptide fractions on resting human peripheral blood mononuclear cells proliferation analysing stimulation indices after 96 h culture.a
Fractionb Concentration (mg mL1)
0.1 1 10 102 103 104
TH 1.20 (0.17) 1.17 (0.25) 1.19 (0.15) 1.23 (0.15) 1.03 (0.28) 0.83 (0.20)
PES-1 1.35 (0.03) 1.04 (0.15) 1.07 (0.30) 1.50 (0.30)*** 1.47 (0.03)** 0.21 (0.05)***
HYD-2 1.26 (0.05) 1.17 (0.18) 1.13 (0.21) 1.34 (0.22)* 1.21 (0.14) 0.85 (0.48)
PES-5 1.30 (0.24) 1.06 (0.15) 1.02 (0.22) 0.93 (0.23) 1.28 (0.20)* 0.61 (0.50)***
DR 1.22 (0.15) 0.94 (0.23) 0.95 (0.08) 1.52 (0.34) 3.64 (1.00)*** 3.73 (1.24)***
a Data are expressed as mean, with standard deviation in parentheses, of 3 independent donors and each fraction was assayed by quadruplicate. Statistical differences
between negative control (unstimulated cells) and the cells cultured with the indicated fraction at the indicated concentration are given (*p< 0.050, **p< 0.010, ***p< 0.001);
differences were assessed by one-way ANOVA and t-Dunnet post-hoc test.
b Fractions are: TH, total hydrolysate; PES-1, 1 kDa polyethersulfone membrane permeate; HYD-2, 2 kDa Hydrosart membrane permeate; PES-5, 5 kDa polyethersulfone
membrane permeate; DR, diaﬁltration retentate.
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both resting and PHA-stimulated cells (Fig. 2). PBMCs cultured in
medium alone and in the presence of PHA were used as controls.
As observed in proliferation assays, the most interesting results
were obtained with resting cells. Fig. 2A shows that, among the
studied fractions, only DR induced an increase in the production of
IFNg. The upregulation of this Th1 cytokine, which was accompa-
nied by an increase in PBMC proliferation, suggests the activation of
antigen speciﬁc memory/effector Th1 lymphocytes, present in the
peripheral blood of healthy individuals. This effect could be related
to the presence of large and acid peptides in this fraction, features
suggestive of an immunogenic ability, as has been previously re-
ported (Saint-Sauveur, Gauthier, Boutin, & Montoni, 2008). The
absence of signiﬁcant results observed in TH cultures was in
accordance with previous data reporting that complex mixtures of
whey protein hydrolysates did not have any impact on IFNg
secretion (Cross & Gill, 1999; Saint-Sauveur et al., 2008).
Unlike the DR fraction, PES-1 and PES-5 did not produce a Th1
stimulatory ability, probably because they were enriched in short
peptides, a feature related to low T cell immunogenicity. These
fractions, however, signiﬁcantly increased the secretion of TNFa, a
proinﬂammatory cytokine mostly produced by activated
monocytes, supporting that they may also inﬂuence immune re-
sponses. Moreover, the most surprising result was the ability of PES-
1 to induce the production of TGFb, a strong tolerogenic and
immunosuppressor cytokine also secreted by activated monocytes.
Furthermore, this induction was only observed at low PES-1 con-
centrations since, in a dose-dependent manner, this fraction
increased TNFa production while it decreased TGFb secretion. Thus,
in spite of the inability of PES-1 and PES-5 to stimulate Th cells, they
may inﬂuence immune responses through the activation of mono-
cytes. This ﬁnding is in line with previous studies reporting the
activation of macrophage function by whey protein hydrolysates
(Gattegno, Migliore-Samour, Saffar, & Jolles, 1988; Li & Mine, 2004).
Monocytes are vital components of innate immunity, mediating
diverse biological functions that are determined by their activation
states. They respond to microbial infection or physiological changes
in the microenvironment differentiating into M1 or M2 macro-
phages. Classical activation by bacterial lipopolysaccharide or in-
ﬂammatory signals leads to the generation of M1 macrophages,
producers of TNFa, while alternative activation leads to the gen-
eration of M2 macrophages, which are anti-inﬂammatory and
produce immunosuppressor cytokines, including TGFb.
Table 4
Effects of different peptide fractions on phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells proliferation analysing stimulation indices (SI)
after 96 h culture.a
Fractionb Concentration (mg mL1)
0.1 1 10 102 103 104
TH 19.60 (0.07) 21.11 (3.18) 18.92 (2.89) 19.78 (2.02) 19.40 (0.93) 15.62 (10.54)
PES-1 12.99 (1.81) 12.55 (8.49) 15.55 (1.20) 13.20 (9.05) 13.17 (9.11) 33.28 (1.79)***
HYD-2 24.29 (2.98) 27.71 (3.85) 25.92 (4.29) 20.26 (5.18) 16.45 (2.09) 30.69 (1.87)*
PES-5 16.90 (0.06) 18.25 (2.42) 14.24 (4.00) 20.46 (2.05) 18.86 (0.11) 29.33 (7.54)***
DR 16.70 (0.15) 16.05 (1.70) 20.00 (2.78)* 30.02 (4.92)*** 17.34 (1.14) 4.59 (0.11)***
a Data are expressed as mean, with standard deviation in parentheses, of 3 independent donors and each fraction was assayed by quadruplicate. PHA-stimulated cells
without peptides provided a SI of 15.59 (1.55) cpm. Statistical differences between negative control (PHA-stimulated cells) and the cells cultured with the indicated fraction at
the indicated concentration are given (*p < 0.050, **p < 0.010, ***p < 0.001). Differences were assessed by one-way ANOVA and t-Dunnet post-hoc test.
b Fractions are: TH, total hydrolysate; PES-1, 1 kDa polyethersulfone membrane permeate; HYD-2, 2 kDa Hydrosart membrane permeate; PES-5, 5 kDa polyethersulfone
membrane permeate; DR, diaﬁltration retentate.
Fig. 2. Cytokine stimulation by different b-lactoglobulin fractions. Interferon gamma (IFNg), tumour necrosis factor alpha (TNFa) and transforming growth factor beta (TGFb) were
measured by ELISA techniques in the supernatants from PBMC after culture with different peptidic fractions. In panel A cells were cultured in the presence of different fractions
under resting conditions, whereas in panel B cells were under phytohaemagglutinin (PHA)-stimulating conditions. Bars represent mean and standard deviation from four different
experiments performed with different blood donors (n ¼ 12). Fraction concentrations are indicated at the bottom of the bars (10e103 mg mL1). Negative control (resting cells,-)
and positive control (PHA-stimulated cells,-) values are indicated in each graph. Differences among all the assayed samples were evaluated by one-way ANOVA and p-values are
indicated at the top of the histogram. Differences between each sample and the control (unstimulated cells in A, PHA-stimulated cells in B) were evaluated by t-Dunnet post-hoc test
and are indicated as *p < 0.05, **p < 0.01, ***p < 0.001.
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Although activation usually arises after exposure to pathogens
or tissue injury, several short peptides, like natural host defence
peptides (HDPs), can also stimulate macrophage differentiation.
Therefore, in recent years there has been an increased effort to
design and develop synthetic peptides, termed innate defence
regulators (IDRs), with enhanced immunomodulatory activities
that depend on uptake into eukaryotic cells, making them an
attractive new anti-infective strategy for their potential value in the
therapy and prophylaxis of infection (Nijnik et al., 2010; Wieczorek
et al., 2010). Therefore, speciﬁc whey-derived peptides could act as
natural IDRs.
On the other hand, the addition of b-LG peptidic fractions to
PHA-stimulated cells did not signiﬁcantly affect cytokine produc-
tion (Fig. 2B), except for the TNFa inhibition observed with high
doses of TH and DR, which seems to be due to a cytotoxic effect on
monocytes. Accordingly, decreased cell viability at these concen-
trations was suggested by the proliferation assays (Table 4).
To summarise, the apparent lack of immune activity displayed
by the TH may be explained by the diverse peptideecell in-
teractions arising in the context of a complex mixture of peptides,
since our results strongly suggested that each particular b-LG
fraction could trigger a characteristic immune ability, which could
lead to opposite effects on one another. In this sense, the TGFb-
inducer potential of PES-1 fraction may be of special interest, due to
the key regulatory effects of this cytokine on many cell types. TGFb
promotes immunoglobulin class switch to IgA, the isotype pre-
dominant in mucosal epithelia, and a crucial mechanism for the
defence against pathogens in the gut. In addition, this cytokine is
required to generate induced Treg cells, especially in peripheral
tissues associated with mucosal surfaces, a population involved in
both the immunological tolerance and the control of excessive
inﬂammation, thus pointing to the relevance of this ﬁnding in the
ﬁeld of allergic and inﬂammatory conditions.
3.4. PES-1 fraction can promote regulatory T cell responses
In view of the previously observed upregulation of TGFb, we
aimed to evaluate whether the PES-1 fraction could inﬂuence the
generation of Treg cells in vitro. Thus, PBMCs were cultured in
medium alone or in the presence of different concentrations (10e
104 mg mL1) of PES-1 fraction or the unfractionated TH. The pro-
portion of Treg cells after 5 days of culture was quantiﬁed by ﬂow
Fig. 3. Enrichment of regulatory T cell (Treg) population by the permeate stream obtained using the 1 kDa polyethersulfone membrane (PES-1 fraction). Human peripheral blood
mononuclear cell (PBMC) phenotype was analysed by ﬂow cytometry after culture with PES-1 fraction or the unfractionated total hydrolysate (TH). For each condition, 30,000 CD4þ
events were analysed. Panel A: Treg frequency (CD4þCD25highCD127FOXP3þ cells) on PBMC after 5-days culture in the presence of PES-1 (-) or TH (,). Bars represent mean and
standard deviation of 5 independent experiments performed with different blood donors (n ¼ 12). Differences between each sample and the negative control were assessed by t-
Dunnet post-hoc test. Panel B: ﬂow cytometry analysis of Treg population by their CD25, CD127 and FOXP3 expression. Frequencies of a representative experiment are shown for the
CD4þCD25highFOXP3þ and CD4þCD25highCD127 populations. **p < 0.01.
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cytometry, analysing CD4, CD25, FOXP3 and CD127 expression
in viable lymphocytes (Fig. 3A). We noticed that the highest dose
(104 mg mL1) caused a decrease in the amount of total viable
cells (76.47 4.90%), supporting the reported cytotoxic effect of this
concentration. However, no differences were observed in the total
CD4þ T lymphocyte population among the different culture
conditions (p > 0.05). Fig. 3A shows that PES-1 fraction at
10 mg mL1 signiﬁcantly increased the percentage of Treg cells
(CD4þCD25highFOXP3þCD127), but they decreased at higher
concentrations in a dose-dependent manner. Similar results were
obtained quantifying separately CD4þCD25highFOXP3þ and
CD4þCD25highCD127 populations (p < 0.01) (Fig. 3B). The TH
fraction had no signiﬁcant effect on these populations at any of the
studied concentrations.
These data are in line with TGFb production and proliferation
results in PES-1 cultures at low concentrations, suggesting the
ability of speciﬁc peptide(s) included in this fraction to modulate
effector immune responses in vitro through the enrichment of Treg
cells, a TGFb-dependent population. Although induction of TGFb
production by whey hydrolysated fractions has been reported in
mice (Saint-Sauveur, Gauthier, Boutin, Montoni, & Fliss, 2009), this
is the ﬁrst study showing a signiﬁcant effect on human cells, and
not only on TGFb, but also on the Treg population.
Our results, however, suggest a dose-dependent effect on
monocyte differentiation. Relatively low doses of the short peptides
included in PES-1 fraction could generate anti-inﬂammatory M2
macrophages by an alternative monocyte activation pathway,
leading to TGFb secretion, whereas higher amounts of these pep-
tides could drive a classic M1 differentiation and TNFa production.
Other hypotheses, however, could also explain these results. Given
that PES-5 fraction was unable to induce TGFb, a speciﬁc peptide(s)
included in PES-1 could be responsible for the effect. Thus, the
peptide f(15e40) was present, at low concentrations, in PES-1 but
not in PES-5. Given that it is 4e7 times larger than most of the other
peptides included in this fraction, the absolute number of mole-
cules present at lower PES-1 concentrations could have a greater
functional impact than in higher ones, where it may be masked by
the large amount of short peptides, since the ratio between the
number of short and long peptides changed. Analysing the effect of
this peptide by itself (i.e., by means of synthesis) would be needed
to conﬁrm our hypothesis.
In line with this, it has been shown that several IDRs suppress
proinﬂammatory responses modulating M1eM2 macrophage dif-
ferentiation (Pena et al., 2013), suppressing potentially harmful
excessive inﬂammatory responses (Scott et al., 2007) and offering
protection by enhancing the innate immune defences of the host,
thus suggesting again that whey-derived peptides could be used as
natural IDRs.
Induction of Treg population, probably through TGFb produc-
tion, as we reported here, could be one of the potentially active
mechanisms by which certain whey peptides exert their suppres-
sive effects. Prevention of type I hypersensitivity reactions is an
area in which milk protein hydrolysis has become increasing rele-
vant (Gauthier et al., 2006), and some immunosuppressive mech-
anisms have been identiﬁed (Prioult, Pecquet, & Fliss, 2004). In fact,
a previous study reported that a b-LG hydrolysate was able to
induce oral tolerance in an animal model of allergy (Fritsche, Pahud,
Pecquet, & Pfeifer, 1997).
4. Conclusions
This study showed diverse ex vivo immune effects triggered by
b-LG separated fractions that were absent in the unfractionated
total hydrolysate. The fraction enriched in acidic and large peptides
increased the secretion of IFNg, a Th1 cytokine implicated in the
control of intracellular pathogens. Conversely, fractions including
short peptides were better stimulants of monocytes than T cells,
leading to TNFa production. However, low doses of one of these
fractions were able to increase TGFb secretion and Treg cells, key
mechanisms for immunological tolerance and the control of in-
ﬂammatory conditions in gut mucosa. This fraction unexpectedly
included a large peptide, probably due to peptideepeptide
interactions.
RTherefore, our results support the use of membrane isolated
whey-derived products in the food, nutraceutical or pharmacolog-
ical industries, not only because of their nutritional value but also for
their immunological activities. In fact, it could be an easy and valu-
able process to obtain bioactive-enriched food products, although
the potential interactions with the background diet could modify
their immune effects, so this limitation must be taken into account.
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